Genevieve Neal-Perry, MD, PhD, discusses the profound impact of vasomotor symptoms on quality of life during menopause and highlights racial disparities that disproportionately affect African American women.
Closing the Gap: Elinzanetant Demonstrates Efficacy for Vasomotor Symptoms in African American Women
Genevieve Neal-Perry, MD, PhD, reviews the design and pooled efficacy results of the OASIS 1 and OASIS 2 trials evaluating elinzanetant (Lynkuet) for moderate to severe vasomotor symptoms.
Genevieve Neal-Perry, MD, PhD, explains how rapid onset of symptom relief with elinzanetant (Lynkuet) may improve patient satisfaction and adherence.
Genevieve Neal-Perry, MD, PhD, discusses how elinzanetant (Lynkuet) improves sleep quality and menopause-related quality of life through its dual neurokinin receptor antagonism.
Genevieve Neal-Perry, MD, PhD, outlines unmet needs in managing vasomotor symptoms among African American women and discusses how elinzanetant (Lynkuet) may help shape more equitable care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring
2
Point-of-care molecular vaginitis testing improves likelihood of appropriate treatment
3
At-home pelvic ultrasound feasible, preferred over in-clinic care
4
Maegan Ashworth Dirac, MD, PhD, discusses slowed global maternal mortality progress
5